This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
As the only pediatric hearttransplant program in Louisiana and the only program in the state to offer advanced mechanical support options for pediatric cardiology patients, Ochsner Children’s Hospital is committed to advocating for additional medical devices to enhance its high-quality care to pediatric patients awaiting transplant.
Early Feasibility Study (FUTURE-HF2) of its FIRE1 System for remote heartfailure monitoring. The FIRE1 System is the first device designed to directly measure a patient’s volume status by measuring the largest vein in the body where most fluid is stored – the inferior vena cava (IVC) – to better manage heartfailure.
David Gibson, 75, of Walbridge, Ohio, traveled 100 miles to undergo care with UH Harrington Heart & Vascular Institute. He was diagnosed with extensive coronary artery disease, resulting in ischemic cardiomyopathy and heartfailure. His heart was weak and did not pump well due to blockages in his coronary arteries.
Adipose-derived mesenchymal stem cells (ASCs) represent an innovative candidate to treat ischemic heart disease (IHD) due to their abundance, renewable sources, minor invasiveness to obtain, and no ethical limitations.
Koonlawee Nademanee, Director of the Bumrungrad Heart Institute in Thailand, have spearheaded the establishment of a world-class heart institute. This institute is dedicated to pioneering research, innovation, and the development of clinically effective techniques for addressing various heart conditions.
suffer from heartfailure , and there are approximately 400,000 heart-failure-related deaths in this country each year. Patients with heartfailure often experience reduced mobility, quality of life and ability to work; the disease also represents a significant public health care burden.
a privately held company dedicated to advancing the treatment of heartfailure ( HF ) at the intersection of digital health and medtech, today announced Premarket Approval (PMA) from the U.S milla1cf Mon, 06/24/2024 - 20:21 June 24, 2024 — Endotronix, Inc. ,
Amputation statistics are bleak, and amputation should be a last resort, said Dr. Shishehbor, President of UH Harrington Heart & Vascular Institute, and Angela and James Hambrick Chair in Innovation at UH. This is why we are passionate about pursuing alternatives to amputation for our patients. When we save a limb, we save a life.
Amputation statistics are bleak, and amputation should be a last resort, said Dr. Shishehbor, President of UH Harrington Heart & Vascular Institute, and Angela and James Hambrick Chair in Innovation at UH. This is why we are passionate about pursuing alternatives to amputation for our patients. When we save a limb, we save a life.
We need a comprehensive and innovative approach to cardiorenal metabolic management and risk reduction to address this challenge. These interconnected diseases pose a significant global health threat, with cardiovascular diseases alone accounting for one-third of all deaths worldwide , according to the World Health Organization.
Anuradha Lala-Trindade, MD: She focuses on the selection and care of patients with mechanical circulatory support devices and hearttransplantation, genetic cardiomyopathies, and perioperative management of high-risk cardiac surgical cases. Become A Mentor: Effective mentorship is vital to career growth and advancement.
Circulation: HeartFailure, Ahead of Print. In 2014, the Organ Procurement and Transplant Network began reappraisal of the United States hearttransplant allocation policy. The number of exception requests continues to increase, particularly for patients listed status 2 and for multiorgan transplants.
We organize all of the trending information in your field so you don't have to. Join thousands of users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content